BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12761131)

  • 21. Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model.
    Bahey-El-Din M; Casey PG; Griffin BT; Gahan CG
    Vaccine; 2008 Sep; 26(41):5304-14. PubMed ID: 18691625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.
    Ozawa Y; Suda T; Nagata T; Hashimoto D; Nakamura Y; Enomoto N; Inui N; Koide Y; Nakamura H; Chida K
    Am J Respir Cell Mol Biol; 2009 Oct; 41(4):440-8. PubMed ID: 19202004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
    Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
    J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of listeriolysin-O (LLO) in the T lymphocyte response to infection with Listeria monocytogenes. Identification of T cell epitopes of LLO.
    Safley SA; Cluff CW; Marshall NE; Ziegler HK
    J Immunol; 1991 May; 146(10):3604-16. PubMed ID: 1709197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective immunity induced by a LLO-deficient Listeria monocytogenes.
    Yin Y; Zhang C; Dong H; Niu Z; Pan Z; Huang J; Jiao X
    Microbiol Immunol; 2010 Apr; 54(4):175-83. PubMed ID: 20377746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel T cell-oriented vaccine using CTL/Th-hybrid epitope long peptide and biodegradable microparticles, against an intracellular bacterium.
    Tanaka K; Enomoto N; Uehara M; Furuhashi K; Sakurai S; Yasui H; Karayama M; Hozumi H; Suzuki Y; Fujisawa T; Inui N; Nakamura Y; Nagata T; Suda T
    Microbiol Immunol; 2020 Oct; 64(10):666-678. PubMed ID: 32786043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant Listeria vaccines containing PEST sequences are potent immune adjuvants for the tumor-associated antigen human papillomavirus-16 E7.
    Sewell DA; Shahabi V; Gunn GR; Pan ZK; Dominiecki ME; Paterson Y
    Cancer Res; 2004 Dec; 64(24):8821-5. PubMed ID: 15604239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo.
    Harty JT; Bevan MJ
    J Exp Med; 1992 Jun; 175(6):1531-8. PubMed ID: 1375265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
    Ikonomidis G; Paterson Y; Kos FJ; Portnoy DA
    J Exp Med; 1994 Dec; 180(6):2209-18. PubMed ID: 7964496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage.
    Jensen S; Steffensen MA; Jensen BA; Schlüter D; Christensen JP; Thomsen AR
    J Immunol; 2013 Oct; 191(8):4152-64. PubMed ID: 24043891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of enhanced CD8 T cell responses following immunization with a hyper-antigen secreting intracytosolic bacterial pathogen.
    Smithey MJ; Brandt S; Freitag NE; Higgins DE; Bouwer HG
    J Immunol; 2008 Mar; 180(5):3406-16. PubMed ID: 18292567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA vaccination with gp96-peptide fusion proteins induces protection against an intracellular bacterial pathogen.
    Rapp UK; Kaufmann SH
    Int Immunol; 2004 Apr; 16(4):597-605. PubMed ID: 15039390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two Listeria monocytogenes vaccine vectors that express different molecular forms of human papilloma virus-16 (HPV-16) E7 induce qualitatively different T cell immunity that correlates with their ability to induce regression of established tumors immortalized by HPV-16.
    Gunn GR; Zubair A; Peters C; Pan ZK; Wu TC; Paterson Y
    J Immunol; 2001 Dec; 167(11):6471-9. PubMed ID: 11714814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the protective immune response to Yersinia pseudotuberculosis infection in mice vaccinated with an LcrV-secreting strain of Lactococcus lactis.
    Daniel C; Titecat M; Poiret S; Cayet D; Boutillier D; Simonet M; Sirard JC; Lemaître N; Sebbane F
    Vaccine; 2016 Nov; 34(47):5762-5767. PubMed ID: 27742220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
    Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
    Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single chain MHC I trimer-based DNA vaccines for protection against Listeria monocytogenes infection.
    Kim S; Zuiani A; Carrero JA; Hansen TH
    Vaccine; 2012 Mar; 30(12):2178-86. PubMed ID: 22285270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Administration of killed bacteria together with listeriolysin O induces protective immunity against Listeria monocytogenes in mice.
    Xiong H; Tanabe Y; Ohya S; Mitsuyama M
    Immunology; 1998 May; 94(1):14-21. PubMed ID: 9708181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-existing anti-Salmonella vector immunity prevents the development of protective antigen-specific CD8 T-cell frequencies against murine listeriosis.
    Sevil Domènech VE; Panthel K; Meinel KM; Winter SE; Rüssmann H
    Microbes Infect; 2007 Oct; 9(12-13):1447-53. PubMed ID: 17913544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effector CD8+ T cells are generated in response to an immunodominant epitope in type III effector YopE during primary Yersinia pseudotuberculosis infection.
    Zhang Y; Mena P; Romanov G; Bliska JB
    Infect Immun; 2014 Jul; 82(7):3033-44. PubMed ID: 24799630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yersinia enterocolitica-mediated translocation of defined fusion proteins to the cytosol of mammalian cells results in peptide-specific MHC class I-restricted antigen presentation.
    Rüssmann H; Weissmüller A; Geginat G; Igwe EI; Roggenkamp A; Bubert A; Goebel W; Hof H; Heesemann J
    Eur J Immunol; 2000 May; 30(5):1375-84. PubMed ID: 10820384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.